omeprazole+domperidone SR + omeprazole
ApprovedUNKNOWN 0 views this week 0 watching💤 Quiet
Interest: 36/100
36
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedAbout omeprazole+domperidone SR + omeprazole
omeprazole+domperidone SR + omeprazole is a approved stage product being developed by Dr. Reddy's Laboratories for GERD. The current trial status is unknown. This product is registered under clinical trial identifier NCT02140073. Target conditions include GERD.
What happened to similar drugs?
8 of 20 similar drugs in GERD were approved
Approved (8) Terminated (0) Active (12)
Hype Score Breakdown
Clinical
20
Activity
4
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02140073 | Approved | UNKNOWN |
Competing Products
20 competing products in GERD
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| OMEZ 40 + OMEZ 80 | Dr. Reddy's Laboratories | Approved | 40 |
| Rabeprazole ER + Ranitidine | Eisai | Phase 3 | 40 |
| Rabeprazole sodium | Eisai | Phase 1 | 29 |
| Rabeprazole sodium + Esomeprazole | Eisai | Phase 3 | 40 |
| rabeprazole sodium + Placebo | Eisai | Phase 3 | 40 |
| Rabeprazole ER + Ranitidine | Eisai | Phase 3 | 40 |
| Rabeprazole sodium 5 mg + Rabeprazole sodium 10 mg | Eisai | Phase 1 | 29 |
| rabeprazole + rabeprazole | Eisai | Phase 3 | 40 |
| Rabeprazole sodium + Esomeprazole | Eisai | Phase 3 | 40 |
| Rabeprazole sodium + Esomeprazole | Eisai | Phase 3 | 40 |
| ONO-8539 | Ono Pharmaceutical | Phase 1 | 29 |
| esomeprazole 40 mg | Johnson & Johnson | Pre-clinical | 26 |
| esomeprazole (Nexium®) + Xolaam® | AstraZeneca | Approved | 43 |
| esomeprazole | AstraZeneca | Pre-clinical | 26 |
| Esomeprazole | AstraZeneca | Approved | 43 |
| Esomeprazole | AstraZeneca | Approved | 43 |
| esomeprazole magnesium | AstraZeneca | Phase 1 | 29 |
| Esomeprazole | AstraZeneca | Approved | 43 |
| Esomeprazole | AstraZeneca | Phase 3 | 40 |
| Esomeprazole (Nexium) | AstraZeneca | Approved | 43 |